Hydrophobic Nanoparticles Reduce the β-Sheet Content of SEVI Amyloid Fibrils and Inhibit SEVI-Enhanced HIV Infectivity
- 1 March 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 33 (10) , 2596-2602
Abstract
Semen-derived enhancer of virus infection (SEVI) fibrils are naturally abundant amyloid aggregates found in semen that facilitate viral attachment and internalization of human immunodeficiency virus (HIV) in cells, thereby increasing the probability of infection. Mature SEVI fibrils are composed of aggregated peptides exhibiting high β-sheet secondary structural characteristics. Herein, we show that polymers containing hydrophobic side chains can interact with SEVI and reduce its β-sheet content by ∼45% compared with the β-sheet content of SEVI in the presence of polymers with hydrophilic side chains, as estimated by polarization modulation-infrared reflectance absorption spectroscopy measurements. A nanoparticle (NP) formulation of this hydrophobic polymer reduced SEVI-mediated HIV infection in TMZ-bl cells by 60% compared with the control treatment. Although these NPs lacked specific amyloid-targeting groups, thus requiring high concentrations to observe biological activity, the use of hydrophobic interactions to alter the secondary structure of amyloids represents a useful approach to neutralizing the SEVI function. These results could, therefore, have general implications in the design of novel materials that can modify the activity of amyloids associated with a variety of other neurological and systemic diseases.Keywords
Funding Information
- California HIV/AIDS Research Program (ID10-SD-034)
- National Institute of Allergy and Infectious Diseases (P30AI078498, R21AI094511, R33AI094511)
This publication has 60 references indexed in Scilit:
- Semen-Derived Enhancer of Viral Infection (SEVI) Binds Bacteria, Enhances Bacterial Phagocytosis by Macrophages, and Can Protect against Vaginal Infection by a Sexually Transmitted Bacterial PathogenAntimicrobial Agents and Chemotherapy, 2013
- Bacterial curli protein promotes the conversion of PAP248-286into the amyloid SEVI: cross-seeding of dissimilar amyloid sequencesPeerJ, 2013
- Seminal Plasma Accelerates Semen-derived Enhancer of Viral Infection (SEVI) Fibril Formation by the Prostatic Acid Phosphatase (PAP248–286) PeptideJournal of Biological Chemistry, 2012
- Naturally Occurring Fragments from Two Distinct Regions of the Prostatic Acid Phosphatase Form Amyloidogenic Enhancers of HIV InfectionJournal of Virology, 2012
- Peptides Released by Physiological Cleavage of Semen Coagulum Proteins Form Amyloids that Enhance HIV InfectionCell Host & Microbe, 2011
- Helical Conformation of the SEVI Precursor Peptide PAP248-286, a Dramatic Enhancer of HIV Infectivity, Promotes Lipid Aggregation and FusionBiophysical Journal, 2009
- The Cationic Properties of SEVI Underlie Its Ability To Enhance Human Immunodeficiency Virus InfectionJournal of Virology, 2009
- Semen-Derived Amyloid Fibrils Drastically Enhance HIV InfectionCell, 2007
- The role of sexually transmitted diseases in HIV transmissionNature Reviews Microbiology, 2004
- Sexual Transmission of HIVNew England Journal of Medicine, 1997